Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) operates in the Financial Services sector, specifically the Shell Companies industry, with a market capitalization near $528.8M, listed on NASDAQ, carrying a beta of 0.04 to the broader market. Drugs Made In America Acquisition II Corp. Led by Roger Bendelac, public since 2025-12-04.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for DMII as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →